These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9563249)

  • 41. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The development and application of an immunoenzyme assay kit for the detection of compounds of the opiate family in human biological liquids].
    Nikolaeva TL; Belkina EV; Bogatyreva EA; Gribkova SE; Proskurina NV; Smirnova VK; Lapenkov MI
    Sud Med Ekspert; 2008; 51(6):33-6. PubMed ID: 19172894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests.
    Musshoff F; Driever F; Lachenmeier K; Lachenmeier DW; Banger M; Madea B
    Forensic Sci Int; 2006 Jan; 156(2-3):118-23. PubMed ID: 16410161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of three commercial tests for buprenorphine screening in urine.
    Leino A; Loo BM
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):563-5. PubMed ID: 17961313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urine toxicology testing in chronic pain management.
    Cone EJ; Caplan YH
    Postgrad Med; 2009 Jul; 121(4):91-102. PubMed ID: 19641275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is the Kentucky prescription reporting system useful in the care of hospitalized patients?
    Blondell RD; Dodds HN; Blondell MN; Droz DC
    J Ky Med Assoc; 2004 Jan; 102(1):15-9. PubMed ID: 14971165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of the Cozart microplate EIA for analysis of opiates in oral fluid.
    Cooper G; Wilson L; Reid C; Baldwin D; Hand C; Spiehler V
    Forensic Sci Int; 2005 Nov; 154(2-3):240-6. PubMed ID: 16182972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Illicit methadone use and abuse in young people accessing treatment for opiate dependence.
    Roche A; McCabe S; Smyth BP
    Eur Addict Res; 2008; 14(4):219-25. PubMed ID: 18679031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug dependence and abuse potential of tramadol.
    Liu ZM; Zhou WH; Lian Z; Mu Y; Ren ZH; Cao JQ; Cai ZJ
    Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):52-4. PubMed ID: 10437125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Self-perceived motivation for benzodiazepine use and behavior related to benzodiazepine use among opiate-dependent patients.
    Fatséas M; Lavie E; Denis C; Auriacombe M
    J Subst Abuse Treat; 2009 Dec; 37(4):407-11. PubMed ID: 19339146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benzodiazepine prescription for patients in opioid maintenance treatment in Norway.
    Bramness JG; Kornør H
    Drug Alcohol Depend; 2007 Oct; 90(2-3):203-9. PubMed ID: 17478058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Opiates].
    Nomoto T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():469-71. PubMed ID: 15658365
    [No Abstract]   [Full Text] [Related]  

  • 53. Why is urine drug testing not used more often in practice?
    Bair MJ; Krebs EE
    Pain Pract; 2010; 10(6):493-6. PubMed ID: 21040440
    [No Abstract]   [Full Text] [Related]  

  • 54. Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky.
    Gilbert JW; Wheeler GR; Mick GE; Storey BB; Herder SL; Richardson GB; Watts E; Gyarteng-Dakwa K; Marino BS; Kenney CM; Siddiqi M; Broughton PG
    Pain Physician; 2010; 13(2):167-86. PubMed ID: 20309383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A nationwide survey of urinalysis practices of methadone maintenance clinics. Utilization of laboratory services.
    Saxon AJ; Calsyn DA; Haver VM; Erickson L
    Arch Pathol Lab Med; 1990 Jan; 114(1):94-100. PubMed ID: 2294873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interference of oxaprozin with benzodiazepines via enzyme immunoassay technique.
    Matuch-Hite T; Jones P; Moriarity J
    J Anal Toxicol; 1995; 19(2):130. PubMed ID: 7769785
    [No Abstract]   [Full Text] [Related]  

  • 57. Reactivity of commercial benzodiazepine immunoassays to phenazepam.
    Kyle PB; Brown KB; Bailey AP; Stevenson JL
    J Anal Toxicol; 2012 Apr; 36(3):207-9. PubMed ID: 22417837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of the use of psychotropic drugs from urine samples from subjects attending for the first time a clinic specializing in opium addiction].
    Bonnand B; Auriacombe M; Franques P; Bertorelle V; Afflelou S; Daulouède JP; Combourieu I; Tignol J
    Presse Med; 1999 Apr; 28(13):679-82. PubMed ID: 10228474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary screening for benzodiazepines with radioreceptor assay: comparison with EMIT d.a.u. benzodiazepine assay and high-performance liquid chromatography.
    Borggaard B; Joergensen I
    J Anal Toxicol; 1994 Sep; 18(5):243-6. PubMed ID: 7990439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opiate DAU screening using dried urine specimens.
    Meany DL; Clarke W
    Clin Chim Acta; 2009 Mar; 401(1-2):188-9. PubMed ID: 19068209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.